SEC Form 4 · accession 0001546417-17-000118
Bloomin' Brands, Inc. · BLMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth A Smith
Officer — Chairman and CEO · Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 9:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001546417
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2017 | M | 125,000 | $6.50 | A | 206,235 | D | |
| Common StockF1,F2 | Dec 15, 2017 | S | 125,000 | $20.79 | D | 81,235 | D | |
| Common StockF1 | Dec 15, 2017 | M | 125,000 | $6.50 | A | 206,235 | D | |
| Common StockF1,F3 | Dec 15, 2017 | S | 125,000 | $20.79 | D | 81,235 | D | |
| Common StockF1 | Dec 15, 2017 | M | 125,000 | $6.50 | A | 206,235 | D | |
| Common StockF1,F4 | Dec 15, 2017 | S | 125,000 | $20.80 | D | 81,235 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F5 | $6.50 | Dec 15, 2017 | M | 125,000 | D | — | Nov 16, 2019 | Common Stock | 125,000 | 2,812,424 | D |
| Stock Option (right to buy)F1,F5 | $6.50 | Dec 15, 2017 | M | 125,000 | D | — | Nov 16, 2019 | Common Stock | 125,000 | 2,687,424 | D |
| Stock Option (right to buy)F1,F5 | $6.50 | Dec 15, 2017 | M | 125,000 | D | — | Nov 16, 2019 | Common Stock | 125,000 | 2,562,424 | D |
| Restricted Stock UnitsF6,F7 | $0.00 | holding | — | — | — | — | — | Common Stock | 84,008 | 84,008 | D |
| Restricted Stock UnitsF8,F7 | $0.00 | holding | — | — | — | — | — | Common Stock | 112,220 | 112,220 | D |
| Stock Option (right to buy)F5 | $10.03 | holding | — | — | — | — | Jul 1, 2021 | Common Stock | 550,000 | 550,000 | D |
| Stock Option (right to buy)F9 | $25.36 | holding | — | — | — | — | Feb 26, 2025 | Common Stock | 220,589 | 220,589 | D |
| Stock Option (right to buy)F10 | $25.32 | holding | — | — | — | — | Feb 27, 2024 | Common Stock | 177,940 | 177,940 | D |
| Stock Option (right to buy)F5 | $10.03 | holding | — | — | — | — | Jul 1, 2021 | Common Stock | 550,000 | 550,000 | D |
| Stock Option (right to buy)F11 | $17.15 | holding | — | — | — | — | Feb 25, 2026 | Common Stock | 261,122 | 261,122 | D |
| Stock Option (right to buy)F12 | $17.27 | holding | — | — | — | — | Feb 24, 2027 | Common Stock | 267,327 | 267,327 | D |
Explanation of responses
- F1This transaction was effected by the reporting person pursuant to a Rule 10b5-1 trading plan that was entered into on November 14, 2017.
- F10These stock options, in the original grant amount of 177,940, began vesting in four equal annual installments on February 27, 2015.
- F11These stock options, in the original grant amount of 261,122, began vesting in four equal annual installments on February 25, 2017.
- F12These stock options, in the original grant amount of 267,327, will begin vesting in four equal annual installments on February 24, 2018.
- F2Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $20.600 to $21.030. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
- F3Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $20.600 to $21.070. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
- F4Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $20.570 to $21.020. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
- F5These stock options are fully vested.
- F6These restricted stock units, in the original grant amount of 112,010, began vesting in four equal annual installments on February 25, 2017.
- F7This field is not applicable.
- F8These restricted stock units, in the original grant amount of 112,220, will begin vesting in four equal annual installments on February 24, 2018.
- F9These stock options, in the original grant amount of 220,589, began vesting in four equal annual installments on February 26, 2016.